Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Yan Ming, holds the title of CHIEF TECHNOLOGY OFFICER at Cytek Biosciences, Inc..
On 2026-11-18, the insider transacted 41,373 shares.The shares were transacted at a weighted average price of $1.16 per share, resulting in a total market-relevant value of $48K.
Yan Ming (CHIEF TECHNOLOGY OFFICER) had withheld for taxes $48K of $CTKB
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.